Literature DB >> 15875057

Chronic periodontal disease is associated with single-nucleotide polymorphisms of the human TLR-4 gene.

N W J Schröder1, D Meister, V Wolff, C Christan, D Kaner, V Haban, P Purucker, C Hermann, A Moter, U B Göbel, R R Schumann.   

Abstract

Periodontitis is an inflammatory disease affecting the connective tissue surrounding the teeth leading to tooth loss. Pathogens associated with periodontitis interact with Toll-like receptors (TLRs) to induce cytokines causing and aggravating disease. We screened 197 individuals suffering from generalized periodontitis for the presence of Asp299Gly and Thr399Ile of TLR-4 as well as Arg753Gln of TLR-2 in comparison to matched controls. Single-nucleotide polymorphisms (SNPs) of TLR-4 were elevated among patients (odd's ratio 3.650, 95% CI 1.573-8.467, P < or = 0.0001), while no difference was observed for TLR-2. TLR-4 SNPs were correlated with chronic periodontitis (odd's ratio 5.562, 95% CI 2.199-14.04, P < or = 0.0001), but not with aggressive periodontitis. This observation was confirmed employing a group of periodontally healthy probands over 60 years of age. These data demonstrate that genetic variants of TLR-4 may act as risk factors for the development of generalized chronic periodontitis in humans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15875057     DOI: 10.1038/sj.gene.6364221

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  31 in total

1.  Trigeminal nociceptors express TLR-4 and CD14: a mechanism for pain due to infection.

Authors:  R Wadachi; K M Hargreaves
Journal:  J Dent Res       Date:  2006-01       Impact factor: 6.116

Review 2.  Beyond good and evil in the oral cavity: insights into host-microbe relationships derived from transcriptional profiling of gingival cells.

Authors:  M Handfield; H V Baker; R J Lamont
Journal:  J Dent Res       Date:  2008-03       Impact factor: 6.116

Review 3.  Toll gates to periodontal host modulation and vaccine therapy.

Authors:  George Hajishengallis
Journal:  Periodontol 2000       Date:  2009       Impact factor: 7.589

4.  Alveolar bone loss in relation to toll-like receptor 4 and 9 genotypes and Porphyromonas gingivalis carriage.

Authors:  U K Gursoy; Q He; P Pussinen; S Huumonen; E Könönen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-04       Impact factor: 3.267

5.  Periodontitis in Chédiak-Higashi Syndrome: An Altered Immunoinflammatory Response.

Authors:  V Thumbigere Math; P Rebouças; P A Giovani; R M Puppin-Rontani; R Casarin; L Martins; L Wang; K Krzewski; W J Introne; M J Somerman; F H Nociti; K R Kantovitz
Journal:  JDR Clin Trans Res       Date:  2017-08-03

6.  Aging and contribution of MyD88 and TRIF to expression of TLR pathway-associated genes following stimulation with Porphyromonas gingivalis.

Authors:  Y B Shaik-Dasthagirisaheb; N Huang; E O Weinberg; S S Shen; C A Genco; F C Gibson
Journal:  J Periodontal Res       Date:  2014-05-24       Impact factor: 4.419

7.  Toll-like receptor 4 gene polymorphism is associated with chronic periodontitis.

Authors:  Yuan-Sheng Ding; Yue Zhao; Yuan-Yuan Xiao; Gang Zhao
Journal:  Int J Clin Exp Med       Date:  2015-04-15

8.  A novel bioactive three-dimensional beta-tricalcium phosphate/chitosan scaffold for periodontal tissue engineering.

Authors:  Feng Liao; Yangyang Chen; Zubing Li; Yining Wang; Bin Shi; Zhongcheng Gong; Xiangrong Cheng
Journal:  J Mater Sci Mater Med       Date:  2009-11-12       Impact factor: 3.896

9.  Scavenger receptor A is expressed by macrophages in response to Porphyromonas gingivalis, and participates in TNF-alpha expression.

Authors:  M T Baer; N Huang; F C Gibson
Journal:  Oral Microbiol Immunol       Date:  2009-12

Review 10.  Functional consequences of toll-like receptor 4 polymorphisms.

Authors:  Bart Ferwerda; Matthew Bb McCall; Karlijn Verheijen; Bart-Jan Kullberg; André Jam van der Ven; Jos Wm Van der Meer; Mihai G Netea
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.